Takeda's $64 Billion Offer Bolstered by Shire's Results

(Bloomberg) -- Shire Plc’s results topped expectations for its latest quarter, bolstering Takeda Pharmaceutical Co.’s case in selling its $64 billion takeover offer to investors.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.